Details of the Drug Combination

General Information of Drug Combination (ID: DCL5C96)

Drug Combination Name
Meglumine gadoterate Iobitridol
Indication
Disease Entry Status REF
Type 2 Diabetes Mellitus Phase 1 [1]
Component Drugs Meglumine gadoterate   DM88FNL Iobitridol   DMXN1CL
Small molecular drug Small molecular drug
2D MOL 2D MOL
3D MOL 3D MOL

References

1 ClinicalTrials.gov (NCT01254552) Assessment With CCTA and MRI in Asymptomatic Patients With Type 2 Diabetes for Detection of Unrecognized Myocardial Scar in Subclinical Coronary Atherosclerosis
2 Radium 223 dichloride for prostate cancer treatment. Drug Des Devel Ther. 2017 Sep 6;11:2643-2651.
3 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015